Adjunctive Nutritional Management of Cancer and Cancer Prevention

This course highlights the peer-reviewed scientific studies, which illustrate the effect to which diet and targeted nutritional supplements impact important biological targets in the prevention and adjunctive nutritional management of cancer. Attendees will learn the mechanism of action through which certain dietary constituents and targeted supplements can favorably affect signal transduction pathways, activation or suppression of various cell membrane growth factor receptors, cytokine receptors, death receptors, apoptosis mechanisms, immune function, transcription factor synthesis and other biological targets of importance. This program provides practitioners with sound scientific support upon which to provide patients with clinically-relevant and practical nutrition and supplementation advice on cancer prevention, as well as a comprehensive approach to the adjunctive nutritional support of cancer, to help prevent recurrence and metastasis. Practitioners will also understand how certain nutritional interventions can enhance the efficacy of certain chemotherapy drugs, and/or reduce the side effects of conventional cancer therapies. Attention to important drug-nutrient interactions regarding classes of chemotherapy drugs is also provided.

Learning Objectives:

1. The student will develop an in-depth understanding of key signal transduction pathways involved in cancer development at a molecular chemistry level.
2. The student will develop an in-depth understanding of the key human clinical trials that have shown efficacy in cancer prevention and the adjunctive management of specific cancers.
3. The student will develop and an in-depth understanding of how commonly used chemotherapy drugs work in the body as well as evidence-based integrative cancer therapies used successfully around the world.
4. The student will have the skills to design an evidence-based, personalized dietary and supplementation program for cancer patients that has the potential to enhance clinical outcomes and work synergistically with any concurrent medical cancer treatments.